Group One Trading’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $511K | Buy |
302,624
+33,154
| +12% | +$68.3K | ﹤0.01% | 3324 |
|
|
2025
Q4 | $534K | Buy |
269,470
+67,854
| +34% | +$217K | ﹤0.01% | 3437 |
|
|
2025
Q3 | $587K | Sell |
201,616
-14,738
| -7% | -$33.9K | ﹤0.01% | 3535 |
|
|
2025
Q2 | $392K | Buy |
216,354
+121,429
| +128% | +$216K | ﹤0.01% | 3669 |
|
|
2025
Q1 | $142K | Buy |
+94,925
| New | +$240K | ﹤0.01% | 4301 |
|
|
2024
Q4 | – | Sell |
-130,789
| Closed | -$2.3M | – | 7880 |
|
|
2024
Q3 | $3.85M | Buy |
+130,789
| New | +$3.01M | 0.01% | 1209 |
|
|
2024
Q2 | – | Sell |
-4,694
| Closed | -$98.9K | – | 7391 |
|
|
2024
Q1 | $95.2K | Buy |
+4,694
| New | +$108K | ﹤0.01% | 4198 |
|
|
2023
Q3 | – | Sell |
-45,936
| Closed | -$910K | – | 8211 |
|
|
2023
Q2 | $1.13M | Buy |
+45,936
| New | +$1.11M | ﹤0.01% | 2243 |
|
|
2023
Q1 | – | Sell |
-104,520
| Closed | -$2.9M | – | 7865 |
|
|
2022
Q4 | $3.09M | Buy |
+104,520
| New | +$3.76M | 0.01% | 1471 |
|
|
2022
Q3 | – | Sell |
-23,682
| Closed | -$640K | – | 8158 |
|
|
2022
Q2 | $666K | Sell |
23,682
-205,082
| -90% | -$5.18M | ﹤0.01% | 3162 |
|
|
2022
Q1 | $8.5M | Buy |
228,764
+142,102
| +164% | +$6.02M | 0.01% | 1116 |
|
|
2021
Q4 | $3.79M | Sell |
86,662
-321,190
| -79% | -$16.8M | ﹤0.01% | 1959 |
|
|
2021
Q3 | $25.3M | Sell |
407,852
-136,733
| -25% | -$11.4M | 0.03% | 516 |
|
|
2021
Q2 | $46.5M | Buy |
544,585
+124,202
| +30% | +$6.65M | 0.06% | 273 |
|
|
2021
Q1 | $18.9M | Buy |
420,383
+358,594
| +580% | +$14.1M | 0.03% | 566 |
|
|
2020
Q4 | $421K | Sell |
61,789
-61,380
| -50% | -$548K | ﹤0.01% | 3425 |
|
|
2020
Q3 | $1.42M | Sell |
123,169
-98,462
| -44% | -$444K | ﹤0.01% | 1879 |
|
|
2020
Q2 | $683K | Buy |
221,631
+212,040
| +2,211% | +$962K | ﹤0.01% | 2364 |
|
|
2020
Q1 | $39K | Buy |
9,591
+9,448
| +6,607% | +$62.5K | ﹤0.01% | 3879 |
|
|
2019
Q4 | $1K | Hold |
143
| – | – | ﹤0.01% | 4988 |
|
|
2019
Q3 | $0 | Hold |
143
| – | – | ﹤0.01% | 5482 |
|
|
2019
Q2 | $0 | Hold |
143
| – | – | ﹤0.01% | 5332 |
|
|
2019
Q1 | $0 | Hold |
143
| – | – | ﹤0.01% | 5293 |
|
|
2018
Q4 | $0 | Hold |
143
| – | – | ﹤0.01% | 5339 |
|
|
2018
Q3 | $0 | Hold |
143
| – | – | ﹤0.01% | 5565 |
|
|
2018
Q2 | $0 | Hold |
143
| – | – | ﹤0.01% | 5417 |
|
|
2018
Q1 | $1K | Hold |
143
| – | – | ﹤0.01% | 4708 |
|
|
2017
Q4 | $1K | Sell |
143
-2,420
| -94% | -$9.77K | ﹤0.01% | 4757 |
|
|
2017
Q3 | $10K | Hold |
2,563
| – | – | ﹤0.01% | 4298 |
|
|
2017
Q2 | $11K | Buy |
2,563
+1
| +0% | +$5 | ﹤0.01% | 4184 |
|
|
2017
Q1 | $16K | Hold |
2,562
| – | – | ﹤0.01% | 3958 |
|
|
2016
Q4 | $10K | Buy |
2,562
+614
| +32% | +$2.85K | ﹤0.01% | 3950 |
|
|
2016
Q3 | $14K | Buy |
+1,948
| New | +$32.3K | ﹤0.01% | 3934 |
|
|
2013
Q4 | – | Sell |
-1,555
| Closed | -$41.3K | – | 5495 |
|
|
2013
Q3 | $30K | Buy |
+1,555
| New | +$27.2K | ﹤0.01% | 3915 |
|
Other funds holding FLNA
VCM
GC
Group One Trading's FLNA Position: Q1 2026 in Review
Group One Trading increased its Filana Therapeutics (FLNA) stake by 12% in Q1 2026, buying an estimated $68.3K and bringing the position to 302,624 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #3324.
Group One Trading first reported a position in FLNA in Q3 2013 and has held it in 34 quarters since. The position peaked at $46.5M in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.
- Group One Trading held 302,624 shares of Filana Therapeutics worth $511K as of Q1 2026.
- Group One Trading bought 33,154 Filana Therapeutics shares in Q1 2026, an estimated $68.3K.
- Filana Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #3324 holding.
- Group One Trading first reported a position in Filana Therapeutics in Q3 2013 and has held it in 34 quarters since.
- Group One Trading's Filana Therapeutics position peaked at $46.5M in Q2 2021.
- 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.
Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.